NJ State Employees Deferred Compensation Plan - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 112 filers reported holding THERAVANCE INC in Q1 2015. The put-call ratio across all filers is 57.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$1,075,000
+46.9%
102,0000.0%0.22%
+39.9%
Q3 2015$732,000
-19.0%
102,000
+104.0%
0.16%
-10.2%
Q2 2015$904,000
+15.0%
50,0000.0%0.18%
+15.8%
Q1 2015$786,000
+11.0%
50,0000.0%0.15%
+10.1%
Q4 2014$708,000
-17.1%
50,0000.0%0.14%
-20.7%
Q3 2014$854,000
-42.7%
50,0000.0%0.17%
-41.0%
Q2 2014$1,490,000
-3.7%
50,0000.0%0.30%
-7.2%
Q1 2014$1,548,00050,0000.32%
Other shareholders
THERAVANCE INC shareholders Q1 2015
NameSharesValueWeighting ↓
Baupost Group 20,395,056$607,365,0009.89%
Realm Partners LLC 301,521$8,979,0003.75%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,805,837$83,558,0002.52%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,447,743$221,794,0002.27%
SECTORAL ASSET MANAGEMENT INC 1,743,188$51,912,0002.20%
Foundation Asset Management, LP 255,790$7,617,0002.19%
Proxima Capital Management, LLC 550,000$16,379,0001.93%
Roundview Capital LLC 140,645$4,188,0001.69%
BB BIOTECH AG 933,244$27,792,0001.32%
PERRY CAPITAL 1,517,208$45,182,0001.25%
View complete list of THERAVANCE INC shareholders